Nirmidas Biotech
San Francisco
About Nirmidas Biotech
Nirmidas provides innovative solutions to life science and healthcare technological problems and aims to improve human life quality for the world. Nirmidas develops, manufactures, and markets breakthrough biological testing, assay and imaging technologies, based on a novel red to near infrared fluorescence enhancing detection platform. We aim to develop personal and portable diagnostics systems for early disease diagnosis and prognosis monitoring, as well as for population-based screening. Our products lie at the intersection of life science research, in vitro diagnosis and digital healthcare.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2016)
- Website: nirmidas.com
- Phone: 408-439-9138
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/nirmidas-biotech-31210 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.